Oxford BioDynamics Statistics
Want to see GB:OBD full AI Analyst Report?
Oxford BioDynamics (OBD) Stock Statistics & Valuation Metrics
Total Valuation
Oxford BioDynamics has a market cap or net worth of GBX 13.44M. The enterprise value is GBX 7.45T.
- Market Cap
- GBX 13.44M
- Enterprise Value
- GBX 7.45T
Share Statistics
Oxford BioDynamics has 13,440,911,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 13,440,911,000
- Owned by Insiders
- 6.46%
- Owned by Institutions
- ―
Financial Efficiency
Oxford BioDynamics’s return on equity (ROE) is -9.99 and return on invested capital (ROIC) is -153.84%.
- Return on Equity (ROE)
- -9.99
- Return on Assets (ROA)
- -1.38
- Return on Invested Capital (ROIC)
- -153.84%
- Return on Capital Employed (ROCE)
- -1.95
- Revenue Per Employee
- 29.59K
- Profits Per Employee
- -301.43K
- Employee Count
- 37
- Asset Turnover
- 0.14
- Inventory Turnover
- 37.15
Valuation Ratios
The current PE Ratio of Oxford BioDynamics is -0.25. Oxford BioDynamics’s PEG ratio is -0.00.
- PE Ratio
- -0.25
- PS Ratio
- 1.78
- PB Ratio
- 1.17
- Price to FCF
- -0.29
- Price to Operating Cash Flow
- -0.52
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Oxford BioDynamics had revenue of 1.09M and earned -11.15M in profits. Earnings per share was -0.01.
- Revenue
- 1.09M
- Gross Profit
- -6.15M
- Operating Income
- -10.66M
- Pretax Income
- -11.42M
- Net Income
- -11.15M
- EBITDA
- -9.80M
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -7.28M and capital expenditures -24,000, giving a free cash flow of -7.30M billion.
- Operating Cash Flow
- -7.28M
- Free Cash Flow
- -7.30M
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Oxford BioDynamics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -317.51%
- Earnings Yield
- -240.39%
Stock Price Statistics
- Beta
- -0.09
- 52-Week Price Change
- -66.10%
- 50-Day Moving Average
- 0.11
- 200-Day Moving Average
- 0.17
- Relative Strength Index (RSI)
- 42.35
- Average Volume (3m)
- 46.46M
Important Dates
Oxford BioDynamics upcoming earnings date is Jan 26, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Jun 30, 2026
- Next Earnings Date
- Jan 26, 2027
- Ex-Dividend Date
- ―
Financial Position
Oxford BioDynamics as a current ratio of 0.88, with Debt / Equity ratio of 457.97%
- Current Ratio
- 0.88
- Quick Ratio
- 0.80
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.38
- Interest Coverage Ratio
- -25.27
Taxes
In the past 12 months, Oxford BioDynamics has paid -269.00K in taxes.
- Income Tax
- -269.00K
- Effective Tax Rate
- 0.02
Enterprise Valuation
Oxford BioDynamics EV to EBITDA ratio is -0.46, with an EV/FCF ratio of -0.56.
- EV to Sales
- 3.40
- EV to EBITDA
- -0.46
- EV to Free Cash Flow
- -0.56
- EV to Operating Cash Flow
- -0.56
Balance Sheet
Oxford BioDynamics has GBX 2.51M in cash and marketable securities with GBX 4.28M in debt, giving a net cash position of -GBX 1.77M billion.
- Cash & Marketable Securities
- GBX 2.51M
- Total Debt
- GBX 4.28M
- Net Cash
- -GBX 1.77M
- Net Cash Per Share
- GBX 0.00
- Tangible Book Value Per Share
- GBX 0.00
Margins
Gross margin is -277.32%, with operating margin of -792.72%, and net profit margin of -825.61%.
- Gross Margin
- -277.32%
- Operating Margin
- -792.72%
- Pretax Margin
- -846.03%
- Net Profit Margin
- -825.61%
- EBITDA Margin
- -743.77%
- EBIT Margin
- -840.17%
Analyst Forecast
The average price target for Oxford BioDynamics is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 33.37%
- EPS Growth Forecast
- 86.41%
Scores
- Smart Score
- ―
- AI Score
- 40
